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ABSTRACT
An increase in the frequency of pulsatile gonadotropin-
releasing hormone (GnRH) secretion in vitro and a reduction
in LH response to GnRH in vivo characterize hypothalamic-
pituitary maturation before puberty in the female rat. In girls
migrating for international adoption, sexual precocity is frequent
and could implicate former exposure to the insecticide
dichlorodiphenyltrichloroethane (DDT), since a long-lasting
DDT derivative has been detected in the serum of such children.
We aimed at studying the effects of early transient exposure to
estradiol (E
2
) or DDT in vitro and in vivo in the infantile female
rat. Using a static incubation system of hypothalamic explants
from 15-day-old female rats, a concentration- and time-
dependent reduction in GnRH interpulse interval (IPI) was seen
during incubation with E
2
and DDT isomers. These effects were
prevented by antagonists of alpha-amino-3-hydroxy-5-methyl-
isoxazole-4 propionic acid (AMPA)/kainate receptors and
estrogen receptor. Also, o,p0-DDT effects were prevented by
an antagonist of the aryl hydrocarbon orphan dioxin receptor
(AHR). After subcutaneous injections of E
2
or o,p0-DDT between
Postnatal Days (PNDs) 6 and 10, a decreased GnRH IPI was
observed on PND 15 as an ex vivo effect. After DDT
administration, serum LH levels in response to GnRH were not
different from controls on PND 15, whereas they tended to be
lower on PND 22. Subsequently, early vaginal opening (VO) and
first estrus were observed together with a premature age-related
decrease in LH response to GnRH. After prolonged exposure to
E
2
between PNDs 6 and 40, VO occurred at an earlier age, but
first estrus was delayed. We conclude that a transient exposure
to E
2
or o,p0-DDT in early postnatal life is followed by early
maturation of pulsatile GnRH secretion and, subsequently, early
developmental reduction of LH response to GnRH that are
possible mechanisms of the subsequent sexual precocity. The
early maturation of pulsatile GnRH secretion could involve
effects mediated through estrogen receptor and/or AHR as well
as AMPA/kainate subtype of glutamate receptors.
environment, estradiol, gonadotropin-releasing hormone,
hypothalamus, puberty
INTRODUCTION
During the past decade, precocious puberty (PP) was
reported to occur frequently in foreign girls after migration for
adoption in different countries of Western Europe. Among the
possible pathophysiologic mechanisms, we have hypothesized
that migration could result in withdrawal from exposure to
estrogenic endocrine-disrupting chemicals (EDCs) in the home
country and cause sexual precocity to occur following early
hypothalamic maturation caused by the EDCs [1, 2]. Those
environmental substances are known to interact with the
reproductive system in a harmful manner [3, 4]. The
involvement of EDCs in sexual precocity in migrating girls
was suggested based on the detection of p,p0-dichlorodiphe-
nyldichloroethene (p,p0-DDE) in the serum of those patients
[1]. With a half-life of several decades, p,p0-DDE is a
persistent derivative of the insecticide dichlorodiphenyltri-
chloroethane (DDT), which has been banned in the United
States of America and Western European countries since the
late 1960s [5, 6] but is still used extensively in developing
countries [2]. This EDC is known to act as an estrogen receptor
(ER) agonist and/or androgen receptor antagonist, both in vitro
and in vivo [7, 8]. In the above situation, because p,p0-DDE
levels were related directly to the length of stay in the country
of origin and inversely to time since immigration [2], it was
thought to be a marker of previous exposure to DDT during
early life.
In immature animals, direct effects on peripheral tissues,
such as the vaginal epithelium, were reported after exposure to
estradiol (E
2
) or estrogenic EDCs and were consistent with
peripheral sexual precocity [7–9]. In 1971, Heinrichs et al.
reported that administration of 1 mg o,p0-DDT in neonatal
female rats on Postnatal Days (PNDs) 2–4 resulted in earlier
vaginal opening (VO) and first estrus and delayed anovulatory
syndrome [10]. They hypothesized that exposure to DDT in
early life could cause premature hypothalamic-pituitary
maturation and disturb the hypothalamic control of ovulation
through unknown mechanisms. Since the o,p0-isomer of DDT
had estrogenic uterotrophic properties [11], the question arose
as to whether central PP could coexist or follow peripheral PP
after exposure to DDT [2, 9]. A hypothalamic effect of
estrogenic substances in the female individual was supported
by our previous observation that E
2
preferentially stimulated
gonadotropin-releasing hormone (GnRH) pulse frequency in
the immature female rat hypothalamus in vitro through a
mechanism dependent on the perinatal sexual differentiation.
In addition, a single massive dose of E
2
given on PND 10
caused early maturation of pulsatile GnRH secretion, with
early VO and first estrus subsequently [12]. The aim of the
present study was to investigate, both in vitro and in vivo, the
effects of an early transient exposure of the immature female
rat hypothalamus and pituitary gland to DDT in comparison
with E
2
and the mechanisms involved in such effects. Two
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particular endpoints were chosen based on developmental
characteristics: the frequency of pulsatile GnRH secretion by
hypothalamic explants in vitro that shows a prepubertal
acceleration between PNDs 10 and 25, as illustrated in Figure
1 [13, 14], and the LH secretory response to a synthetic GnRH
administration in vivo that shows a prepubertal reduction until
PND 36 [15, 16].
MATERIALS AND METHODS
Animals
Infantile female Wistar rats were purchased from the University of Lie`ge.
They were housed in standardized conditions with lactating dams (228C, lights
on from 0630 to 1830 h, food and water ad libitum). Each litter contained 5–10
pups. The day of birth was considered PND 1. The weaning occurred on PND
21. All experiments were carried out with the approval of the Belgian Ministry
of Agriculture and the Ethical Committee at the University of Lie`ge.
Hypothalamic Explant Incubation and GnRH Assay
The developmental variations in GnRH pulse frequency in vitro were
studied using hypothalamic explants obtained in female rats on PNDs 1, 5, 10,
15, 20, 25, 30, and 50. For the in vitro study of hypothalamic explants, 15-day-
old animals were used. After decapitation, the hypothalamus was rapidly
dissected. The limits to obtain the retrochiasmatic hypothalamus were the
caudal margin of the optic chiasm, the caudal margin of the mammillary bodies,
and the lateral hypothalamic sulci [14]. Each explant was transferred into an
individual chamber in a static incubator, as described in detail previously [12,
14]. Each chamber contained 500 ll minimum essential medium (MEM)
supplemented with glucose, magnesium, glycine, and bacitracin to achieve final
concentrations of 25 3 103, 103, 108, and 2 3 105 M, respectively. The




for a total period
varying between 4 and 6 h. The incubation medium was collected and renewed
every 7.5 min and was kept frozen until assayed.
The GnRH release in the incubation medium of hypothalamic explants was
measured in duplicate using a radioimmunoassay method with intraassay and
interassay coefficients of variation of 14% and 18%, respectively [17, 18]. The
highly specific CR11-B81 anti-GnRH antiserum (final dilution 1:80 000) was
kindly provided by Dr. V. D. Ramirez (Urbana, IL) [19]. The data below the
limit of detection (5 pg/7.5-min fraction) were assigned that value.
GnRH Stimulation Test and LH Assay
At PNDs 15 and 22, and at VO and first estrus, serum LH levels were
measured in basal conditions (s.c. injection of vehicle or o,p0-DDT) and 30 min
after stimulation through s.c. injection of 1 lg/kg GnRH. These conditions
were used after testing different time points (15, 30, and 45 min) following
GnRH at different ages (15 and 20 days and at VO) and were consistent with
the conditions reported by others [16, 20].
After 2 h of clotting at room temperature, trunk blood collected from the
killed animals was centrifuged (5 min at 20003 g). The serum was collected
and stored at 208C until assayed. Serum LH levels were determined in
duplicate in a volume of 100 ll using a double-antibody method and
radioimmunoassay kits kindly supplied by the National Institutes of Health (Dr.
A.F. Parlow, National Institute of Diabetes and Digestive & Kidney Diseases,
National Hormone and Peptide Program, Torrance, CA). Rat LH-I-8 was
labeled with 125I by the chloramine-T method. The hormone concentrations
were expressed using the reference preparation rLH-RP-3 as a standard. The
intraassay and interassay coefficients of variation were 7% and 9%,
respectively. The sensitivity limit of the assay was 5 ng/ml.
Reagents




triene); the two DDT isomers, o,p0-DDT (2,40-DDT) and p,p0-DDT (4,4’-
DDT); and p,p0-DDE (4,4 0-DDE) were purchased from Sigma-Aldrich
(Bornem, Belgium). P,p0-DDT represents approximately 80% of the insecticide
still commonly used in developing countries. O,p0-DDT is an equally active
isomer of the insecticide that accounts for 15%–20% of technical grade DDT.
In endocrine studies, o,p0-DDT has been particularly studied due to its
prominent estrogenic property and relatively less toxic activity. P,p0-DDE is a
long-lasting derivative of p,p0-DDT, with a half-life of several years. The a-
amino-3-hydroxy-5-methylisoxazole-4 propionic acid (AMPA)/kainate subtype
of glutamate receptor antagonist DNQX (6,7-dinitroquinoxaline-2,3-dione) and
the ER antagonist ICI 182 780 (7a,17b-[9[(4,4,5,5,5-pentafluoropentyl)sulfi-
nyl]nonyl]-1,3,5(10)-estratriene-3,17b-diol) were purchased from Tocris Fisher
Bioblock Scientific (Illkirch, France), whereas the aryl hydrocarbon orphan
dioxin receptor (AHR) antagonist a-naphtoflavone (7,8-benzoflavone) was
purchased from Sigma-Aldrich. In all experiments, the steroid and insecticides
were dissolved initially in absolute ethanol (Labonord, Templenars, Belgium)
and, subsequently, in the incubation medium or sesame oil (Calbiochem VWR
International, Leuven, Belgium) for in vitro or in vivo studies, respectively, to
FIG. 1. Experimental design to study in
vivo the effects of E
2
or o,p0-DDT treatment
started in 6-day-old female rats as daily s.c.
injections and maintained for 5, 10, or 35
days. The procedure is represented in
relation to age with reference to the
developmental reduction in GnRH IPI
observed in vitro (n ¼ 6). The average ages
at VO and first estrus are also represented.
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achieve a final ethanol concentration of 0.01% or 1%. The antagonists were
directly diluted in the incubation medium.
Study Protocols
In vitro experiments. The in vitro effects of E
2
or DDT on the frequency of
pulsatile GnRH secretion were studied. The compounds (steroid, DDT isomers,
and antagonists) were used for a whole 4- or 6-h experimental incubation
period. A concentration-response study was carried out with explants incubated
with 109 to 107 M of E
2
and 106 to 104 M of o,p0-DDT, p,p0-DDT, or p,p0-
DDE. The effects of antagonists were studied in the presence of maximal
effective concentrations of E
2
and o,p0-DDT. Those antagonists were chosen
because they were shown to prevent E
2
effects on GnRH secretion in our
hypothalamic explant conditions [12, 21], and it was our hypothesis that DDT
effects, if any, could be mediated through mechanisms similar to E
2
effects.
The antagonist DNQX (106 M) was used to study the involvement of the
AMPA/kainate subtype of glutamate receptors. The implication of ER was
studied using the antagonist ICI 182 780 (107 M). To investigate the
implication of AHR, the antagonist a-naphtoflavone (107 M) was used. The
concentration of these three antagonists was selected based on previous data
from our laboratory and other studies [12, 17, 21–23]. It was shown previously
that when used alone, the AMPA/kainate subtype of glutamate receptor and ER
antagonists did not affect pulsatile GnRH secretion [12], and the absence of
effects of the different antagonists when used alone was double checked in this
study.
In vivo experiments. The procedures are schematically summarized in
Figure 1. The animals received a daily s.c. administration of steroid or
insecticide for 5, 10, or 35 days (E
2
: 0.01, 0.1, or 1 mg/kg/day for PNDs 6–10
and 0.01 mg/kg/day for PNDs 6–15 and PND 6–40; o,p0-DDT: 10 or 100 mg/
kg/day for PNDs 6–10 and 10 mg/kg/day for PNDs 6–15). The dose of E
2
and
o,p0-DDT was adjusted for increasing body weight of rats. The chemicals
dissolved in absolute ethanol were diluted in 50 ll sesame oil for s.c. injection,
as described in other studies [24, 25]. When the treatment period was PNDs 6–
10, 20 rats were studied in each treated group in comparison with 20 controls
injected with vehicle alone. On PND 15, 10 rats from each group were killed to
study the pulsatile GnRH secretion in vitro and serum LH levels. In each group,
the 10 remaining animals were then examined daily for imperforation of the
vaginal membrane to determine age at VO. Thereafter, vaginal smears were
taken every day in the afternoon until PND 60. Slides of vaginal smears were
colored using the Papanicolaou method to detect the occurrence of estrous
cyclicity and to follow cycling. The age at first estrus was considered when
vaginal smears contained primary cornified cells after the first proestrous phase,
which is characterized by both stratified and cornified cells [26]. In subsequent
experiments to study LH response to GnRH on PNDs 15 and 22, and at the
time of VO and first estrus, seven animals were killed in each group at each
age. When the treatment period was PNDs 6–15, there were five rats in each
group that were killed on PND 15 to study the GnRH pulse frequency and
serum LH levels. When the treatment period was PNDs 6–40, there were 10
rats followed in each condition to study VO and estrous cyclicity.
Statistical Analysis
When pulsatile GnRH secretion was studied, the peaks were detected using
the PULSAR program for PC [27]. The cutoff criteria for peak detection were
determined empirically and were G
1
¼ 2.5 and G
2
¼ 2.0. Peak splitting
parameter was set at 2.7, and intraassay coefficient of variation was used as B
coefficient [28]. The GnRH interpulse interval (IPI) was calculated as the time
interval between two consecutive peaks. The IPI was calculated during different
time periods of incubation (1–2 h and 3–4 h or 5–6 h). Depending on the
normal or nonnormal distribution of IPI data in the different study periods,
comparisons were made using the paired Student t-test with P , 0.05 as the
threshold for significance (GraphPad Prism software for PC) or the Wilcoxon
matched pairs test, respectively. In several instances, all the explants in a group
showed a similar IPI value. In this case, SD was null and could not be
represented.
When comparisons were made between steroid and/or insecticide effects on
LH levels and age at VO or first estrus in different conditions, raw data were
pooled and analyzed by the one-way ANOVA test when normally distributed,
followed by a multiple-comparison Newman-Keuls post-hoc test when the
threshold for significance of differences (P , 0.05) was reached. When data
were not normally distributed, the Kruskal-Wallis test was used, followed by a
multiple-comparison Dunn post-hoc test. For the experiment run PNDs 6–40,
an unpaired t-test was employed. All results are expressed as mean 6 SD.
RESULTS
In Vitro Treatments
In control conditions of hypothalamic explant incubation in
vitro (Fig. 1), the GnRH IPI showed a reduction between PNDs
10 and 25, confirming our data in the male [13]. When
hypothalamic explants obtained at 15 days were incubated in
control conditions (Fig. 2), the GnRH IPI did not change with
time (1–2 h: 60.4 6 1.7 min; 3–4 h: 59.6 6 1.8 min; and 5–6
h: 60.0 6 0.0 min). During a 4-h continuous incubation with
107 M of E
2
, the GnRH IPI was reduced significantly after 1–
2 h (49.0 6 3.9 min) and further after 3–4 h (45.4 6 1.7 min).
This effect was dependent on E
2
concentration and incubation
time: with 108 M E
2
, the GnRH IPI was unchanged after 1–2
h and decreased significantly after 3–4 h; with 109 M E
2
, a
significant reduction occurred after 5–6 h only (52.5 6 0.0
min). The two active isomers of DDT also caused a
concentration- and time-dependent reduction in GnRH IPI that
was significant after 3–4 h using 105 M of both isomers (o,p0-
DDT: 50.4 6 5.7 min; p,p0-DDT: 52.5 6 0.0 min). At a 104
M concentration, both isomers resulted in an earlier effect that
was also greater after 3–4 h (o,p0-DDT: 45.0 6 0.0 min; p,p0-
DDT: 52.5 6 0.0 min). When used at 106 M, p,p0-DDT had
no effect during a 6-h incubation, and o,p0-DDT showed a
significant effect only after 5–6 h of incubation (52.5 6 0.0
min). No effect could be obtained using p,p0-DDE at similar
concentrations.
The significant reduction of GnRH IPI caused by 107 M E
2
or 104 M o,p0-DDT after 3–4 h of incubation in vitro (Fig. 3A)
was totally prevented when the AMPA/kainate subtype of
glutamate receptors was antagonized by coincubation with
DNQX (Fig. 3B). Likewise, the effects of E
2
and o,p0-DDT
were totally prevented in the presence of the ER antagonist ICI
182 780 (Fig. 3C). When a-naphtoflavone was used to
antagonize the AHR, the significant decrease in GnRH IPI
caused by o,p0-DDT was not observed any more, whereas the
E
2
effect was attenuated but remained significant (Fig. 3D).
In Vivo Treatments
As shown in Figure 4A, after 5 days of treatment with 0.01,
0.1, and 1 mg/kg E
2
(PNDs 6–10), the age at VO (controls:
FIG. 2. Effects of E
2
, DDT isomers, and p,p0-DDE in vitro on the
frequency of pulsatile GnRH secretion from hypothalamic explants
obtained in 15-day-old female rats. The data are calculated in relation
to time (two or three consecutive 2-h periods) of incubation in vitro. a: P,
0.05 versus control; b: P , 0.05 versus data obtained during the initial 2-h
period.
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FIG. 3. Effects of 106 M DNQX, an antagonist of the AMPA/kainate subtype of glutamate receptors (B), 107 M of ICI 182 780, an ER antagonist (C), and
107 M a-naphtoflavone, an AHR antagonist (D) on the GnRH IPI during incubation of hypothalamic explants obtained in 15-day-old female rats in the
presence of 107 M E
2
or 104 M o,p0-DDT (A) in vitro. A representative profile of pulsatile GnRH secretion is shown in each condition, and the mean (6
SD) IPI observed during 3–4 h of incubation are given. *P , 0.05 treatment versus control conditions.
FIG. 4. Effects of E
2
or o,p0-DDT injected
s.c. in female rats for PNDs 6–10 or PNDs
6–40 on the ages at VO and first estrus (A)
and the interval between VO and first estrus
(B). *P , 0.05 versus vehicle (sesame oil).
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30.1 6 0.6 days) was significantly earlier (23.0 6 0.7, 22.7 6
1.3, and 24.6 6 0.5 days, respectively). The VO was also
earlier after 10 and 100 mg/kg o,p0-DDT (22.6 6 0.5 and 24.6
6 0.7 days, respectively). The first estrus was observed on
PND 31.9 6 0.7 in controls and occurred significantly earlier
after 0.01 and 0.1 mg/kg of E
2
(27.2 6 0.7 and 27.5 6 1.1
days), as well as after 10 mg/kg o,p0-DDT (26.4 6 1.5 days).
After 1 mg/kg E
2
or 100 mg/kg o,p0-DDT, the age at first estrus
did not change. When the time interval between VO and first
estrus (Fig. 4B) was calculated (controls: 1.8 6 0.9 days), a
significant dose-dependent increase was observed after 0.1 and
1 mg/kg E
2
or 100 mg/kg o,p0-DDT. No differences in estrus
cycle length were observed until PND 60 (Table 1).
As shown in Figure 5A, after five daily s.c. injections of
0.01, 0.1, and 1 mg/kg E
2
(PNDs 6–10), the GnRH IPI studied
ex vivo on PND 15 (controls: 60.0 6 0.0 min) was
significantly reduced (54.4 6 3.3, 52.5 6 0.0, and 47.0 6
3.4 min, respectively). A reduction of GnRH IPI was also seen
after treatment with 10 and 100 mg/kg/day o,p0-DDT, which
was only significant with 100 mg/kg (55.0 6 3.6 min). When
0.01 mg/kg E
2
or 10 mg/kg o,p0-DDT was administered for a
longer period of 10 days (PNDs 6–15), the GnRH IPI ex vivo
was significantly reduced on PND 15 as well.
As shown in Figure 5B, the serum LH level on PND 15
(controls: 41.1 6 19.9 ng/ml) was significantly decreased after
0.01, 0.1, and 1 mg/kg E
2
between PNDs 6 and 10 (18.9 6
12.7, 23.7 6 13.8, and 9.7 6 3.0 ng/ml, respectively) and after
10 and 100 mg/kg o,p0-DDT (22.7 6 18.5 and 15.7 6 6.0 ng/
ml, respectively). However, the serum LH level also decreased
with age after sesame oil (control) administration (Fig. 6): 48.2
6 46.7 ng/ml on PND 15, 25.8 6 19.3 on PND 22, 16.5 6
13.7 on PND 30.6 6 1.5 (at VO), and 10.5 6 7.3 on PND 35.0
TABLE 1. Mean 6 SD (n¼ 10) of estrous cycle length (interval between
two consecutive estrus) observed until PND 60.
Treatment Dose (mg/kg) Estrous cycle length (days)
PND 6–10
Vehicle — 4.7 6 1.4
E2 0.01 5.2 6 1.6
0.10 5.5 6 1.8
1.00 4.6 6 1.5
o,p’-DDT 10.00 5.3 6 2.0
100.00 5.5 6 1.4
PND 6–40
Vehicle — 4.8 6 1.2
E2 0.01 4.9 6 1.8
FIG. 5. Effects of E
2
or o,p0-DDT injected
s.c. in female rats for PNDs 6–10 or PNDs
6–15 on the GnRH IPI (A) and serum LH
concentrations (B) studied ex vivo at 15
days of age. *P , 0.05 versus vehicle
(sesame oil).
FIG. 6. Effects of treatment of female rats with o,p0-DDT (10 mg/kg/day)
or sesame oil for PNDs 6–10 on serum LH levels studied 30 min after
subcutaneous injection of 1 lg/kg GnRH at four age points: PND 15, PND
22, the day of VO, and the day of first estrus. The data are mean 6 SD of
LH levels and age in seven rats studied in each group. *P , 0.05 versus
vehicle (sesame oil).
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6 1.2 (at first estrus). When the LH response to GnRH was
studied after vehicle or 10 mg/kg o,p0-DDT given for PNDs 6–
10, the LH response was not affected on PND 15 and showed
some but not significant reduction on PND 22, whereas it
dropped significantly in the next days, at the time of early VO
and first estrus.
An extended period of daily s.c. administration of 0.01 mg/
kg E
2
for PNDs 6–40 (Fig. 4A) caused a significantly earlier
age at VO (22.1 6 1.0 vs. 31.8 6 1.0 days in controls),
whereas the age at first estrus was significantly delayed (47.1
6 0.8 vs. 35.4 6 1.7 days in controls), and the interval
between VO and first estrus was markedly increased (20.6 6
1.2 vs. 3.6 6 2.2 days in controls). The first estrus was
observed after a permanent estrus lasting until a few days after
the end of treatment. Then, no differences in estrous cycle
length were observed until PND 60 (Table 1). After daily s.c.
administration of 10 mg/kg o,p0-DDT for PNDs 6–40, the
animals showed altered health status with reduced activity and
feeding. On PND 40, their weight was significantly decreased
to 111.3 6 8.3 g (130.0 6 11.5 g after E
2
and 149.0 6 9.9 g in
controls). In such conditions, it was no longer possible to
separate direct o,p0-DDT effects on sexual maturation and
reproduction from indirect effects through disordered nutri-
tional status.
DISCUSSION
The hypothalamic explant paradigm used in this study
provided an opportunity to observe pulsatile GnRH secretion in
vitro as the result of GnRH neuron function in its original
surrounding neuronoglial apparatus, which regulates GnRH
secretion [29]. Moreover, the developmental changes in
frequency of pulsatile GnRH secretion retained in this model
[13] made possible the study of interaction with maturational
processes, although the critical age period for the develop-
mental increase in GnRH pulse frequency was earlier in vitro
[14] than in vivo [30, 31]. Such a difference could involve
suppression of inhibitory extrahypothalamic inputs when
explants are deafferented from the rest of the brain. However,
the critical period of the second and third postnatal weeks in
our conditions is consistent with neuroendocrine maturation
preceding the peripheral changes of sexual maturation (VO,
testicular growth). Since we incubated retrochiasmatic hypo-
thalami containing prominently axons and terminals of GnRH-
secreting neurons [32], we tend to interpret our observations as
the effects of presynaptic regulation by the surrounding
neurons and glial cells. Other in vitro paradigms involving
GnRH neurons, such as GnRH-secreting neuronal cell lines
[33–35], primary cultures of hypothalamic neurons [36–38], or
hypothalamic slices from transgenic mice carrying reporter
genes linked to the GnRH promoter [39] could enable one to
study directly the regulatory mechanisms at the GnRH neuron
level.
The present study was designed to test experimentally the
hypothesis that early and transient exposure to pesticide, as
seen in internationally adopted children, could influence
hypothalamic-pituitary maturation and account for some
central mechanism in the sexual precocity occurring frequently
in such conditions. Since p,p0-DDE, which was detected in the
serum of those children, was thought to result from previous
exposure to DDT, this EDC was used for in vivo treatment.
After we observed that o,p0-DDT and p,p0-DDT were almost
equally effective on GnRH pulse frequency in vitro, the o,p0-
DDT isomer was preferred for in vivo investigations based on
its greater estrogenicity and lower toxicity than p,p0-DDT. In
addition, o,p0-DDT was the isomer used in former studies on
the neuroendocrine control of reproduction [10, 11, 40–42].
The doses that we used for in vivo studies and the E
2
:o,p0-DDT
concentration ratio were based on our in vitro data reported in
the present study and were comparable with those used in other
studies in rodents [43, 44]. The 10 and 100 mg/kg doses were
in the same range as the amounts given by others either
neonatally [10] or around the time of weaning [11]. After early
postnatal administration, lower doses appeared to have no
effects on age at VO and gonadotropin secretion [41]. It was
not possible in this study to measure the concentrations of DDT
isomers and derivatives in serum and tissues. The quantitative
relevance of our conditions of exposure to DDT when
compared to the exposure of migrating girls was difficult to
assess, since the only available information was p,p0-DDE
concentrations measured in serum several years later. After
early DDT treatment in neonatal rats for 3 days, p,p0-DDE
measured in adipose tissue 4–5 mo later was not different from
controls, suggesting clearance of the insecticide and its residues
after that long period [10]. After 7 days of daily oral intake of
p,p0-DDT in a daily dose equivalent to 106 mg/kg in 5-wk-old
rats, serum p,p0-DDE levels attained a mean level of 0.66 mg/l
[45]. Such a serum concentration was about 20 times higher
than the serum concentrations found in migrating children [1].
We, however, observed significant neuroendocrine effects
using a 10-times-lower DDT dose that would presumably
result in lower serum DDT levels. Further comparison would
require measurement of the different DDT isomers and residues
at different time points after stopping DDT treatment in the
animals. The interpretation of doses and exposure is even more
complex, since migrating children are likely to be exposed to
various EDCs both in the original and foster countries. It has
been reported that when chemicals are used in mixtures,
combination effect could require lower concentrations than
expected based on simply additive effects [46]. Moreover,
when animals undergo low-dose exposure, the dose-effect
relationship is not linear with comparatively greater effects of
low versus high doses. Although these aspects have not been
investigated in the present study, they could be important for
the pathophysiologic relevance of our findings.
The age window of PNDs 6–10 could be consistent with
early postnatal period in human infants. A 5-day period of
treatment was relatively short for the lifespan but significant
with respect to the short time period between birth and sexual
maturation in the rat. The use of female rats aged 15 days to
study GnRH IPI was based on our previous data showing that
GnRH secretion in vitro was maximally affected by E
2
in such
conditions [12]. With hypothalamic explants from younger
females (5 days), GnRH secretion was also found to be
responsive to E2, but such age falls in the critical window of the
brain sexual differentiation, causing possible interferences with
programming of estrus cyclicity. This conclusion was drawn by
Heinrichs et al., who found early VO and delayed persistent
estrus to occur after DDT treatment for PNDs 2–4 [10].
Discrepant observations were made when o,p0-DDT treatment
was started at 3 wk of age for several weeks: Gellert et al.
found VO to occur earlier [11], whereas Wrenn et al. found no
change in age at VO that was hastened only when treatment
was given before the age of 3 wk [40]. In the present study,
treatment during the second week of postnatal life was a
compromise to possibly affect sexual maturation without
interfering with the sexually differentiated mechanism of
ovulation. However, such interferences probably did occur
using the highest E
2
and DDT concentrations, since they did
not result in early first estrus as opposed to lower doses.
Alternatively, toxic effects could have occurred, although the
nonsignificantly affected growth in those short treatment
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conditions did not support such an hypothesis. Three periods
were chosen for in vivo exposure based on the attempt to
mimic the either temporary or persisting exposure of children
either migrating from or staying in developing countries. In the
case of temporary exposure, two different lengths were studied
(until PND 10 or 15) in order to investigate whether duration
could influence the effect. This was confirmed since, after
exposure for 10 instead of 5 days, the lowest dose of DDT
became significantly effective in reducing the GnRH IPI, and
the lowest dose of E
2
became more effective.
As many other EDCs, the DDT isomers were shown to
exhibit both estrogenic and antiandrogenic properties, whereas
p,p0-DDE retained only antiandrogenic activity [7, 8]. Because
the clinical observation was made in girls [1], and E
2
was
found to preferentially influence GnRH secretion in the female
rat hypothalamus [12], female rats were used in the present
study. In our experimental conditions, it was shown previously
that both E
2
and testosterone could accelerate GnRH pulse
frequency, the effect of androgens being aromatase dependent
and ultimately mediated through estrogens [12]. Therefore, we
hypothesized that the estrogenic activity of DDT was also
involved in the pathogenesis of sexual precocity [1, 2, 9]. This
hypothesis was consistent with our previous observation of
sexual precocity after a single massive administration of E
2
on
PND 10 [12], although the use of lower doses for a longer time
period needed to be investigated. For all these reasons, E
2
was
used as a positive control in this work to provide a comparison
basis with DDT effects in vitro and in vivo.
Direct incubation of hypothalamic explants with E
2
or DDT
isomers resulted in a concentration- and time-dependent
increase in GnRH pulse frequency. The 1:1000 potency ratio
of E
2
:DDT found in our conditions was consistent with other
studies [47]. P,p0-DDE had no effect, which is in agreement
with the absence of estrogenlike effects reported in other
conditions [48]. Although supraphysiologic concentrations of
E
2
were required for an effect within 1–2 h, lower
concentrations became effective after few hours of incubation.
Such a delay could be explained by the slow diffusion of
reagents into the explant, a hypothesis consistent with the
observation that greater concentrations of compounds like
excitatory amino acids are needed in explant paradigms
compared with neuronal culture systems [49]. Another
explanation could be the latency before the possibly genomic
mechanisms involved in E
2
effects became effective. Then E
2
effects on GnRH secretion could have a rapid, presumably
nongenomic component, as illustrated by Matagne et al. [21] in
our paradigm, together with a slow genomic component. In this
case, the target would be other cells than GnRH neurons, since
GnRH cell bodies are absent from the studied retrochiasmatic
explants [32]. Herbison [50] and, more recently, Herbison and
Pape [51] have also reported that E
2
exerts complex effects on
the GnRH neuronal function, including long-term or genomic
effects through binding to ERa and/or ERb subtypes. In our
system, the acceleration of pulsatile GnRH secretion caused by
E
2
was prevented by ICI 182 780, an a/b ER antagonist, as well
as by DNQX, an antagonist of the AMPA/kainate subtype of
glutamate receptors, confirming our previous observations
[12]. The involvement of AMPA/kainate subtypes of glutamate
receptors in E
2
stimulation of GnRH pulse frequency was
further supported by the hypothalamic colocalization of those
receptors together with ER [52]. Since the effects of o,p0-DDT
were also prevented by ICI 182 780 and DNQX, this EDC
appeared to involve the same receptors as E
2
. However, the
receptor pathway involved in o,p0-DDT effects could be partly
different, with a participation of the orphan dioxin AHR, as
indicated by the preferential reduction of o,p0-DDT effects by
the antagonist a-naphtoflavone. The investigation of the
insecticide effect through this pathway was justified, since
Ohtake et al. [23] reported a few years ago that dioxins can
mimic the effect of estrogens via a mechanism that involves the
activation of ER by the transcriptionally active AHR-aryl
hydrocarbon nuclear translocator complex. Further studies
could delineate the relative contribution of the a- and b-




administration in immature rodents, an inhibition
of LH secretion was commonly observed [53, 54] and impeded
the use of variations in LH secretion to investigate indirectly
hypothalamic effects. In addition, there is physiologically a
developmental reduction in serum LH concentrations between
PND 15 and VO, both basally and in response to GnRH [15,
16], so that decreased LH levels could result from either
negative feedback effects or accelerated maturation or both.
Therefore, hypothalamic-pituitary maturation was assessed
through evaluation of GnRH secretion during explant incuba-
tion and study of LH response to GnRH after steroid or EDC
administration in vivo. We elected to study GnRH secretion at
15 days using explants from female rats based on our previous
studies showing that the frequency of pulsatile GnRH secretion
in vitro was maximally stimulated by E
2
in such conditions and
through a mechanism dependent on perinatal brain sexual
differentiation [12]. The exposure of infantile female rats to E
2
or o,p0-DDT for 5 or 10 days was followed by a dose-
dependent increase in GnRH pulse frequency and a decrease in
serum LH levels on PND 15, suggesting a stimulation of
hypothalamic maturation and a negative feedback inhibition or
an early maturation of the pituitary secretion. A negative
feedback component at the hypothalamic and/or pituitary level
was supported by the reduction in the postcastration rise of
serum LH levels that was reported after treatment of mature or
neonatal rats with o,p0-DDT [11, 41]. However, no change in
LH secretion basally and in response to GnRH was found in
another study 6 wk after o,p0-DDT treatment between PNDs 1
and 10 [42]. The unchanged LH response to GnRH on PNDs
15 and 22 suggests that the result of the combined inhibitory
and stimulatory effects at those stages is a steady state. Then,
early VO could result from either a peripheral effect of E
2
or
DDT or early pituitary-ovarian activity or both. A central
component at the time of VO is suggested by the brisk
reduction in LH response to GnRH that was observed in the
treated animals. Subsequently, early first estrus possibly
confirmed premature activity of the hypothalamic-pituitary-
ovarian axis. Such a pathophysiologic mechanism could be
consistent with an involvement of DDT in the sexual precocity
occurring after migration in internationally adopted children [1,
2, 9]. In a recent Danish study of such children, it was shown
that developmental changes in pituitary-ovarian hormone levels
were observable before onset of puberty and supported a
hypothalamic-pituitary mechanism of early puberty [55]. Since
our report of an association between sexual precocity and the
detection of p,p0-DDE in the serum of migrating girls [1], early
menarche was found to occur after prenatal or postnatal
exposure to DDE and/or DDT [56, 57]. However, others did
not observe changes in menarcheal age after prenatal or
postnatal exposure to DDE [58, 59], and postnatal treatment of
female monkeys with methoxychlor resulted in delayed nipple
development and menarche [60]. Further studies are warranted
to clarify the possible role of EDC nature and parameters of
exposure (age, dose, duration) in those discrepant effects. In
rodents, discrepant observations were made as well, since
pesticides such as methoxychlor and lindane resulted, respec-
tively, in precocity and delay in the age at VO, but both
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insecticides caused disturbances of estrous cyclicity [61–63],
and decreased serum LH levels were reported after lindane
administration [61]. The GnRH neuron itself could be targeted
by EDCs, since the phytoestrogen coumestrol caused inhibitory
effects on GnRH transcript expression in GT1–7 GnRH-
secreting neuronal cells through the b subtype of ER [64].
When E
2
was injected for PND 6–40, early VO followed by
permanent estrus was observed. After E
2
treatment was
stopped, first estrus appeared at a markedly delayed age. This
could indicate a peripheral stimulatory effect of the steroid
together with a central inhibition during exposure. A slight
anorexigenic effect of E
2
was observed, consistent with studies
previously reported by Ramirez and Sawyer [65] and by
Ramirez [66], whereas o,p0-DDT caused a dramatic decrease in
body weight, suggesting a possible toxic effect of the
insecticide [45].
In summary, evidence that DDT could influence the
infantile female hypothalamic pituitary maturation was pro-
vided through early developmental acceleration of the GnRH
secretion in vitro and early reduction of LH response to GnRH
in vivo. It was also demonstrated that this chemical caused a
precocious onset of puberty in vivo when immature individuals
were transiently exposed to DDT. Further studies will aim to
delineate its mechanism of action and address whether the
GnRH neurons or other cell structures are primary targets.
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